Evaluate the Immunogenicity of a Novel Glucagon Formulation

Conditions

• Drug-specific Antibodies
• Diabetes Mellitus

Interventions

• DRUG: Nasal Glucagon (NG)
• DRUG: Glucagon IM

Sponsor

Eli Lilly and Company

Collaborators

• [object Object]